or Try an Advanced Search...

    Technical Analysis for PASG - Passage Bio, Inc.

    Grade Last Price % Change Price Change
    F 0.89 11.43% 0.09
    PASG closed up 11.43 percent on Monday, July 1, 2024, on 2.78 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical PASG trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    180 Bearish Setup Bearish Swing Setup 11.43%
    Expansion Breakdown Bearish Swing Setup 11.43%
    Reversal New Lows Setup Bearish Swing Setup 11.43%
    Outside Day Range Expansion 11.43%
    Wide Bands Range Expansion 11.43%
    Oversold Stochastic Weakness 11.43%
    Older End-of-Day Signals for PASG ...

       Recent Intraday Alerts

    Alert Time
    Up 3% about 9 hours ago
    Up 2% about 9 hours ago
    Up 1% about 9 hours ago
    Down 5% 3 days ago
    Down 10% 3 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    PASG Chart by TradingView
    Basic chart:

    Profile

    Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine products, which includes PBGM01 for the treatment of GM1, PBFT02 for the treatment of FTD and PBKR03 for the treatment of Krabbe disease. Passage Bio was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Organ Systems Rare Diseases Central Nervous System Disorders Nervous System Disorders Lipid Storage Disorders Monogenic Medicine Products Gm1 Rare Tadataka Yamada

    Is PASG a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 5 Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
    May 16 All You Need to Know About Passage Bio (PASG) Rating Upgrade to Buy
    May 14 Passage Bio GAAP EPS of -$0.30
    May 14 Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
    Apr 22 Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
    Mar 5 Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship Program
    Mar 4 Passage Bio files for $200M mixed shelf offering
    Mar 4 Passage Bio GAAP EPS of -$1.86 beats by $0.04
    Mar 4 Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights
    Feb 27 Passage Bio to Participate in Upcoming Investor Conferences
    See more PASG news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.79
    52 Week Low 0.5751
    Average Volume 114,097
    200-Day Moving Average 1.02
    50-Day Moving Average 1.19
    20-Day Moving Average 1.03
    10-Day Moving Average 0.91
    Average True Range 0.11
    RSI (14) 34.64
    ADX 21.03
    +DI 12.19
    -DI 24.88
    Chandelier Exit (Long, 3 ATRs) 1.01
    Chandelier Exit (Short, 3 ATRs) 1.11
    Upper Bollinger Bands 1.31
    Lower Bollinger Band 0.76
    Percent B (%b) 0.23
    BandWidth 53.33
    MACD Line -0.10
    MACD Signal Line -0.09
    MACD Histogram -0.0099
    Fundamentals Value
    Market Cap 48.52 Million
    Num Shares 54.8 Million
    EPS -2.05
    Price-to-Earnings (P/E) Ratio -0.43
    Price-to-Sales 0.00
    Price-to-Book 0.43
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.10
    Resistance 3 (R3) 1.09 1.01 1.06
    Resistance 2 (R2) 1.01 0.95 1.01 1.05
    Resistance 1 (R1) 0.95 0.92 0.98 0.96 1.04
    Pivot Point 0.87 0.87 0.88 0.87 0.87
    Support 1 (S1) 0.81 0.81 0.84 0.82 0.73
    Support 2 (S2) 0.73 0.78 0.73 0.72
    Support 3 (S3) 0.67 0.73 0.71
    Support 4 (S4) 0.68